12-21558177-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_021957.4(GYS2):c.1422+23C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.774 in 1,321,506 control chromosomes in the GnomAD database, including 398,444 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.72 ( 40451 hom., cov: 31)
Exomes 𝑓: 0.78 ( 357993 hom. )
Consequence
GYS2
NM_021957.4 intron
NM_021957.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.56
Publications
10 publications found
Genes affected
GYS2 (HGNC:4707): (glycogen synthase 2) The protein encoded by this gene, liver glycogen synthase, catalyzes the rate-limiting step in the synthesis of glycogen - the transfer of a glucose molecule from UDP-glucose to a terminal branch of the glycogen molecule. Mutations in this gene cause glycogen storage disease type 0 (GSD-0) - a rare type of early childhood fasting hypoglycemia with decreased liver glycogen content. [provided by RefSeq, Dec 2009]
GYS2 Gene-Disease associations (from GenCC):
- glycogen storage disorder due to hepatic glycogen synthase deficiencyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 12-21558177-G-C is Benign according to our data. Variant chr12-21558177-G-C is described in ClinVar as Benign. ClinVar VariationId is 261466.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.777 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GYS2 | NM_021957.4 | c.1422+23C>G | intron_variant | Intron 11 of 15 | ENST00000261195.3 | NP_068776.2 | ||
| GYS2 | XM_024448960.2 | c.1422+23C>G | intron_variant | Intron 11 of 16 | XP_024304728.1 | |||
| GYS2 | XM_006719063.4 | c.1191+23C>G | intron_variant | Intron 10 of 14 | XP_006719126.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GYS2 | ENST00000261195.3 | c.1422+23C>G | intron_variant | Intron 11 of 15 | 1 | NM_021957.4 | ENSP00000261195.2 | |||
| ENSG00000285854 | ENST00000647960.1 | n.*1424+23C>G | intron_variant | Intron 18 of 22 | ENSP00000497202.1 | |||||
| ENSG00000285854 | ENST00000648372.1 | n.1372C>G | non_coding_transcript_exon_variant | Exon 11 of 11 |
Frequencies
GnomAD3 genomes AF: 0.725 AC: 110049AN: 151870Hom.: 40414 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
110049
AN:
151870
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.765 AC: 191420AN: 250296 AF XY: 0.767 show subpopulations
GnomAD2 exomes
AF:
AC:
191420
AN:
250296
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.781 AC: 913207AN: 1169518Hom.: 357993 Cov.: 16 AF XY: 0.781 AC XY: 465427AN XY: 595964 show subpopulations
GnomAD4 exome
AF:
AC:
913207
AN:
1169518
Hom.:
Cov.:
16
AF XY:
AC XY:
465427
AN XY:
595964
show subpopulations
African (AFR)
AF:
AC:
16641
AN:
27994
American (AMR)
AF:
AC:
34549
AN:
44286
Ashkenazi Jewish (ASJ)
AF:
AC:
16850
AN:
24316
East Asian (EAS)
AF:
AC:
30090
AN:
38270
South Asian (SAS)
AF:
AC:
63520
AN:
80252
European-Finnish (FIN)
AF:
AC:
42846
AN:
53284
Middle Eastern (MID)
AF:
AC:
3301
AN:
5218
European-Non Finnish (NFE)
AF:
AC:
667483
AN:
845208
Other (OTH)
AF:
AC:
37927
AN:
50690
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
9733
19466
29200
38933
48666
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
13926
27852
41778
55704
69630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.725 AC: 110142AN: 151988Hom.: 40451 Cov.: 31 AF XY: 0.729 AC XY: 54130AN XY: 74288 show subpopulations
GnomAD4 genome
AF:
AC:
110142
AN:
151988
Hom.:
Cov.:
31
AF XY:
AC XY:
54130
AN XY:
74288
show subpopulations
African (AFR)
AF:
AC:
24940
AN:
41410
American (AMR)
AF:
AC:
11202
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
2388
AN:
3468
East Asian (EAS)
AF:
AC:
3870
AN:
5152
South Asian (SAS)
AF:
AC:
3828
AN:
4814
European-Finnish (FIN)
AF:
AC:
8550
AN:
10558
Middle Eastern (MID)
AF:
AC:
180
AN:
294
European-Non Finnish (NFE)
AF:
AC:
53197
AN:
67998
Other (OTH)
AF:
AC:
1410
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1483
2967
4450
5934
7417
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
844
1688
2532
3376
4220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2606
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oct 23, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Glycogen storage disorder due to hepatic glycogen synthase deficiency Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.